Back to Search
Start Over
Grade 3 lymphomatoid granulomatosis in a patient receiving methotrexate therapy for rheumatoid arthritis.
- Source :
-
Internal medicine (Tokyo, Japan) [Intern Med] 2014; Vol. 53 (16), pp. 1873-5. Date of Electronic Publication: 2014 Aug 15. - Publication Year :
- 2014
-
Abstract
- Lymphomatoid granulomatosis (LyG) is a rare, B-cell derived, lymphoproliferative disorder that often presents as pulmonary nodular lesions with a histopathology of lymphatic invasion of the vascular wall. The development of LyG may be associated with reactivation of the Epstein-Barr virus under an immunosuppressive state. We herein report a case of Grade 3 LyG that developed during methotrexate therapy for rheumatoid arthritis and regressed following the withdrawal of the drug.
- Subjects :
- Aged
Antirheumatic Agents administration & dosage
Female
Glucocorticoids administration & dosage
Humans
Lung Neoplasms diagnostic imaging
Lung Neoplasms drug therapy
Lung Neoplasms pathology
Lymphomatoid Granulomatosis diagnostic imaging
Lymphomatoid Granulomatosis drug therapy
Lymphomatoid Granulomatosis pathology
Methotrexate administration & dosage
Prednisolone administration & dosage
Radiography
Sulfasalazine administration & dosage
Treatment Outcome
Antirheumatic Agents adverse effects
Lung Neoplasms chemically induced
Lymphomatoid Granulomatosis chemically induced
Methotrexate adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7235
- Volume :
- 53
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Internal medicine (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 25130128
- Full Text :
- https://doi.org/10.2169/internalmedicine.53.2593